PIL Readability Testing is Mandatory in EAEUFebruary 15, 2022
Participation in the CPhI Worldwide 2018
Our company had the pleasure to participate in the world’s largest pharmaceutical exhibition, CPhI Worldwide on 9-11 October 2018 in Madrid.
For the first time in our history, we were honored to participate in such a large-scale worldwide exhibition. Our Member of the board Dr. Polina Dombure made a presentation about "CIS Market: Regulatory Strategies in Dynamic Convergence", also including a presentation about Prudenta, a solution for monitoring adverse drug reactions in the local medical literature.
CPhI Worldwide houses six individual pharma events covering all industry sectors. We can not disagree that CPhI is uniting over 45,000 pharma professionals from around the globe and more than 2,500 international exhibitors and it is the place to network and source cost-effective pharma solutions from all over the world. In just three days under one roof, we had a chance to connect & network with international exhibitors and pharma professionals.
See you in Frankfurt next time!
Пользовательское тестирование по ЕАЭС – обязательная процедураFebruary 14, 2022
One More Inpharmatis Team Member Gets PhD in Pharmaceutical SciencesJanuary 27, 2022
В штате Inpharmatis стало на одного доктора фармацевтических наук большеJanuary 27, 2022
Pharma 4.0: Data-Driven RegulationJanuary 18, 2022
Pharma 4.0: от управления на основе документов к решениям, основанным на данныхJanuary 18, 2022
New Inpharmatis Russian Office Phone NumberJanuary 05, 2022
Изменение контактных данных российского офиса InpharmatisJanuary 05, 2022
Inpharmatis Team Participated in the Russian Healthcare ForumDecember 16, 2021
Inpharmatis принял участие в работе форума «Российская неделя здравоохранения»December 16, 2021